Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Virag

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for measuring cardiac physiology in miceMerry L Lindsey, Zamaneh Kassiri, Jitka A I Virag, et al.
The American Journal of Pathology|September 18, 2007
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionJitka A I Virag, Marsha L Rolle, Julia Reece, et al.
Frontiers in Physiology|May 6, 2014
Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathyWesley T O'Neal, William F Griffin, Susan D Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2025
Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later lifeSoroush Taherkhani, Mohammad Sheibani, Ronak Ahmadi, et al.
Human Gene Therapy|May 24, 2007
Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted heartsKelly R Stevens, Marsha W Rolle, Elina Minami, et al.
Journal of the American Society for Mass Spectrometry|January 7, 2018
Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry ImagingStephan Lefcoski, Kimberly Kew, Shaun Reece, et al.
Medical Hypotheses|April 9, 2013
Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarctionWesley T O'Neal, William F Griffin, Jessica L Dries-Devlin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2007
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune responseJeannette Nussbaum, Elina Minami, Michael A Laflamme, et al.
International Journal of Molecular Sciences|August 23, 2020
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M miceK'Shylah S Whitehurst, Victoria A Chan, Heather K Estes, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 12, 2010
Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2Jitka A I Virag, Jessica L Dries, Peter R Easton, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for measuring cardiac physiology in miceMerry L Lindsey, Zamaneh Kassiri, Jitka A I Virag, et al.
The American Journal of Pathology|September 18, 2007
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionJitka A I Virag, Marsha L Rolle, Julia Reece, et al.
Frontiers in Physiology|May 6, 2014
Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathyWesley T O'Neal, William F Griffin, Susan D Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2025
Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later lifeSoroush Taherkhani, Mohammad Sheibani, Ronak Ahmadi, et al.
Human Gene Therapy|May 24, 2007
Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted heartsKelly R Stevens, Marsha W Rolle, Elina Minami, et al.
Journal of the American Society for Mass Spectrometry|January 7, 2018
Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry ImagingStephan Lefcoski, Kimberly Kew, Shaun Reece, et al.
Medical Hypotheses|April 9, 2013
Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarctionWesley T O'Neal, William F Griffin, Jessica L Dries-Devlin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2007
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune responseJeannette Nussbaum, Elina Minami, Michael A Laflamme, et al.
International Journal of Molecular Sciences|August 23, 2020
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M miceK'Shylah S Whitehurst, Victoria A Chan, Heather K Estes, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 12, 2010
Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2Jitka A I Virag, Jessica L Dries, Peter R Easton, et al.
Pageof 4